The once-monthly drug is still under study but could provide added convenience and another option for patients.

A new drug from California-based pharma company Amgen, which has concluded a phase II trial, shows promise as a powerful ...

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...

Key Takeaways One shot a month of an experimental drug yielded promising results in a new clinical trialThe drug, called ...

Thousand Oaks, California Wednesday, June 25, 2025, 13:00 Hrs [IST] ...

An experimental obesity drug has shown it can “substantially” reduce weight within a year, offering new hope for people with ...

If the drug is more broadly used in people with obesity and not just diabetes, those with higher body weights may see even ...

A new monthly weight loss drug, MariTide, helped people shed up to 20% of body weight in a Phase 2 trial—comparable to Wegovy ...

Researchers found that once-monthly maridebart cafraglutide led to substantial weight loss and improved glycemic control in ...